112 related articles for article (PubMed ID: 15127571)
1. [Protective effect of ONO-1078, a leukotriene receptor antagonist, on focal cerebral ischemia induced by endothelin-1 in rats].
Zhang SH; Wei EQ; Zhu CY; Chen Z; Zhang SF
Yao Xue Xue Bao; 2004 Jan; 39(1):1-4. PubMed ID: 15127571
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotective effect of ONO-1078, a leukotriene receptor antagonist, on focal cerebral ischemia in rats.
Zhang WP; Wei EQ; Mei RH; Zhu CY; Zhao MH
Acta Pharmacol Sin; 2002 Oct; 23(10):871-7. PubMed ID: 12370090
[TBL] [Abstract][Full Text] [Related]
3. [Protective effect of ONO-1078, a leukotriene antagonist, on focal cerebral ischemia in mice].
Zeng LH; Zhang WP; Wang RD; Wang PL; Wei EQ
Yao Xue Xue Bao; 2001 Feb; 36(2):148-50. PubMed ID: 12579886
[TBL] [Abstract][Full Text] [Related]
4. HAMI 3379, a CysLT2R antagonist, dose- and time-dependently attenuates brain injury and inhibits microglial inflammation after focal cerebral ischemia in rats.
Shi QJ; Wang H; Liu ZX; Fang SH; Song XM; Lu YB; Zhang WP; Sa XY; Ying HZ; Wei EQ
Neuroscience; 2015 Apr; 291():53-69. PubMed ID: 25681271
[TBL] [Abstract][Full Text] [Related]
5. Montelukast, a cysteinyl leukotriene receptor-1 antagonist, dose- and time-dependently protects against focal cerebral ischemia in mice.
Yu GL; Wei EQ; Zhang SH; Xu HM; Chu LS; Zhang WP; Zhang Q; Chen Z; Mei RH; Zhao MH
Pharmacology; 2005 Jan; 73(1):31-40. PubMed ID: 15452361
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotective effect of ONO-1078, a leukotriene receptor antagonist, on transient global cerebral ischemia in rats.
Zhang LH; Wei EQ
Acta Pharmacol Sin; 2003 Dec; 24(12):1241-7. PubMed ID: 14653951
[TBL] [Abstract][Full Text] [Related]
7. ONO-1078 reduces NMDA-induced brain injury and vascular cell adhesion molecule-1 expression in rats.
Zhang LH; Wei EQ
Acta Pharmacol Sin; 2005 Apr; 26(4):435-40. PubMed ID: 15780192
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of cysteinyl leukotriene receptor-1 in the brain mediates neuronal damage and astrogliosis after focal cerebral ischemia in rats.
Fang SH; Wei EQ; Zhou Y; Wang ML; Zhang WP; Yu GL; Chu LS; Chen Z
Neuroscience; 2006 Jul; 140(3):969-79. PubMed ID: 16650938
[TBL] [Abstract][Full Text] [Related]
9. [An improved quantitative method for evaluating neurological deficits in mice with focal cerebral ischemia].
Wei EQ; Zhu CY; Xu QQ; Yu YP; Zhu YF; Zheng MZ
Sheng Li Xue Bao; 2003 Dec; 55(6):742-7. PubMed ID: 14695495
[TBL] [Abstract][Full Text] [Related]
10. Leukotriene receptor antagonists, LY293111 and ONO-1078, protect neurons from the sPLA2-IB-induced neuronal cell death independently of blocking their receptors.
Yagami T; Yamamoto Y; Kohma H
Neurochem Int; 2013 Sep; 63(3):163-71. PubMed ID: 23792223
[TBL] [Abstract][Full Text] [Related]
11. Intracerebroventricular injection of HAMI 3379, a selective cysteinyl leukotriene receptor 2 antagonist, protects against acute brain injury after focal cerebral ischemia in rats.
Shi QJ; Xiao L; Zhao B; Zhang XY; Wang XR; Xu DM; Yu SY; Fang SH; Lu YB; Zhang WP; Sa XY; Wei EQ
Brain Res; 2012 Nov; 1484():57-67. PubMed ID: 23000196
[TBL] [Abstract][Full Text] [Related]
12. Pranlukast reduces neutrophil but not macrophage/microglial accumulation in brain after focal cerebral ischemia in mice.
Chu LS; Wei EQ; Yu GL; Fang SH; Zhou Y; Wang ML; Zhang WP
Acta Pharmacol Sin; 2006 Mar; 27(3):282-8. PubMed ID: 16490162
[TBL] [Abstract][Full Text] [Related]
13. Pranlukast, a cysteinyl leukotriene receptor-1 antagonist, protects against chronic ischemic brain injury and inhibits the glial scar formation in mice.
Yu GL; Wei EQ; Wang ML; Zhang WP; Zhang SH; Weng JQ; Chu LS; Fang SH; Zhou Y; Chen Z; Zhang Q; Zhang LH
Brain Res; 2005 Aug; 1053(1-2):116-25. PubMed ID: 16051204
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotective effect of immunosuppressant FK506 in transient focal ischemia in rat: therapeutic time window for FK506 in transient focal ischemia.
Arii T; Kamiya T; Arii K; Ueda M; Nito C; Katsura KI; Katayama Y
Neurol Res; 2001 Oct; 23(7):755-60. PubMed ID: 11680517
[TBL] [Abstract][Full Text] [Related]
15. An analysis of four different methods of producing focal cerebral ischemia with endothelin-1 in the rat.
Windle V; Szymanska A; Granter-Button S; White C; Buist R; Peeling J; Corbett D
Exp Neurol; 2006 Oct; 201(2):324-34. PubMed ID: 16740259
[TBL] [Abstract][Full Text] [Related]
16. [Protective effect of hydroxysafflor yellow A on experimental cerebral ischemia in rats].
Zhu HB; Wang ZH; Tian JW; Fu FH; Liu K; Li CL
Yao Xue Xue Bao; 2005 Dec; 40(12):1144-6. PubMed ID: 16496682
[TBL] [Abstract][Full Text] [Related]
17. The interleukin-1 receptor antagonist (rhIL-1ra) protects against cerebral infarction in a rat model of hypoxia-ischemia.
Martin D; Chinookoswong N; Miller G
Exp Neurol; 1994 Dec; 130(2):362-7. PubMed ID: 7867766
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotective effects of erythromycin on cerebral ischemia reperfusion-injury and cell viability after oxygen-glucose deprivation in cultured neuronal cells.
Katayama Y; Inaba T; Nito C; Ueda M; Katsura K
Brain Res; 2014 Nov; 1588():159-67. PubMed ID: 25264351
[TBL] [Abstract][Full Text] [Related]
19. Caffeic acid ameliorates early and delayed brain injuries after focal cerebral ischemia in rats.
Zhou Y; Fang SH; Ye YL; Chu LS; Zhang WP; Wang ML; Wei EQ
Acta Pharmacol Sin; 2006 Sep; 27(9):1103-10. PubMed ID: 16923329
[TBL] [Abstract][Full Text] [Related]
20. Exacerbation of ischemic brain damage by localized striatal injection of interleukin-1beta in the rat.
Stroemer RP; Rothwell NJ
J Cereb Blood Flow Metab; 1998 Aug; 18(8):833-9. PubMed ID: 9701344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
